BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the publication of a clinical study evaluating Ibex ...
Current breast cancer diagnosis practices, such as mammograms and ultrasounds, are usually effective tools. However, they don’t always yield the right results. For instance, according to the NIH’s ...
Trastuzumab deruxtecan improves survival in HER2-low and HER2-ultralow breast cancer, necessitating accurate patient classification. AI significantly enhances pathologists' accuracy in HER2 ...
NASHUA, N.H., Dec. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc (ICAD). (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today ...
Leveraging natural language processing to understand financial toxicity in cancer care: A thematic and sentiment analysis of online patient narratives. This is an ASCO Meeting Abstract from the 2025 ...
Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. Over the next 12 months, tens of thousands of women across ...
iCAD partners with RamSoft to integrate AI-powered breast health solutions into radiology platforms, enhancing diagnostic efficiency and patient care. iCAD, Inc. and RamSoft have announced a strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results